Decreased correlation between the agarose leukocyte migration inhibition assay and delayed cutaneous hypersensitivity response to purified protein derivative in cancer patients.
D001500:BCG Vaccine / Q000627:therapeutic use; D002464:Cell Migration Inhibition; D006801:Humans; D006968:Hypersensitivity, Delayed; D066298:In Vitro Techniques; D007962:Leukocytes / Q000276:immunology*; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D012685:Sepharose; D014373:Tuberculin; D014374:Tuberculin Test
D001500:BCG Vaccine; D014373:Tuberculin; D012685:Sepharose